18F and18FDG PET imaging of osteosarcoma to non-invasively monitor in situ changes in cellular proliferation and bone differentiation upon MYC inactivation

Cancer Biology and Therapy

Volumn 7, Issue 12, 2008, Pages 1947-1951

  Arvanitis, Constadina ^a   Bendapudi, Pavan K ^a   Tseng, Jeffrey R ^a   Gambhir, Sanjiv Sam ^a   Felsher, Dean W ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

18F; 18FDG; Metastasis; MYC; Osteosarcoma; PET; Trangenic mouse model

Indexed keywords

DOXYCYCLINE; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; MYC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MINERALIZATION; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG UPTAKE; HISTOPATHOLOGY; MOUSE; NONHUMAN; OSTEOSARCOMA; POSITRON EMISSION TOMOGRAPHY;

EID: 58149114610     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.7.12.6947     Document Type: Article

References (19)

1. http://www.cancer.org.
2. Bruland OS, Pihl A. On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy. Eur J Cancer 1997; 33:1725-31.
3. Dimitrakopoulou-Strauss A, Hohenberger P, Strobel P, Marx A, Strauss LG. A recent application of fluoro-18-deoxyglucose positron emission tomography, treatment monitoring with a mammalian target of rapamycin inhibitor: an example of a patient with a desmoplastic small round cell tumor. Hell J Nucl Med 2007; 10:77-9.
4. Kumar R, Chauhan A, Kesav Vellimana A, Chawla M. Role of PET/PET-CT in the management of sarcomas. Expert Rev Anticancer Ther 2006; 6:1241-50.
5. Wu CH, van Riggelen J, Yetil A, Fan AC, Bachireddy P, Felsher DW. Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation. Proc Natl Acad Sci USA 2007; 104:13028-33.
6. Jain M, Arvanitis C, Chu K, Dewey W, Leonhardt E, Trinh M, Sundberg CD, Bishop JM, Felsher DW. Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science 2002; 297:102-4.
7. Sturm SA, Strauss PG, Adolph S, Hameister H, Erfle V. Amplification and rearrangement of c-myc in radiation-induced murine osteosarcomas. Cancer Res 1990; 50:4146-53.
8. Gamberi G, Benassi MS, Bohling T, Ragazzini P, Molendini L, Sollazzo MR, Pompetti F, Merli M, Magagnoli G, Balladelli A, Picci P. C-myc and c-fos in human osteosarcoma: prognostic value of mRNA and protein expression. Oncology 1998; 55:556-63.
9. Ell PJ. The contribution of PET/CT to improved patient management. Br J Radiol 2006; 79:32-6.
10. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, Lubbert H, Bujard H. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 1996; 93:10933-8.
11. Felsher DW, Bishop JM. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell 1999; 4:199-207.
12. Tse N, Hoh C, Hawkins R, Phelps M, Glaspy J. Positron emission tomography diagnosis of pulmonary metastases in osteogenic sarcoma. Am J Clin Oncol 1994; 17:22-5.
13. 18F]fluoride ion and PET. J Comput Assist Tomogr 1993; 17:34-41.
14. Brenner W, Bohuslavizki KH, Eary JF. PET imaging of osteosarcoma. J Nucl Med 2003; 44:930-42.
15. Schirrmeister H, Guhlmann A, Kotzerke J, Santjohanser C, Kuhn T, Kreienberg R, Messer P, Nussle K, Elsner K, Glatting G, Trager H, Neumaier B, Diederichs C, Reske SN. Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol 1999; 17:2381-9.
16. 18F PET. J Nucl Med 1999; 40:1623-9.
17. Schirrmeister H, Glatting G, Hetzel J, Nussle K, Arslandemir C, Buck AK, Dziuk K, Gabelmann A, Reske SN, Hetzel M. Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer. J Nucl Med 2001; 42:1800-4.
18. Beer S, Zetterberg A, Ihrie RA, McTaggart RA, Yang Q, Bradon N, Arvanitis C, Attardi LD, Feng S, Ruebner B, Cardiff RD, Felsher DW. Developmental Context Determines Latency of MYC-Induced Tumorigenesis. PLoS Biol 2004; 2:332.
19. Loening AM, Gambhir SS. AMIDE: a free software tool for multimodality medical image analysis. Mol Imaging 2003; 2:131-7.